| Log EC150 | Log EC250 | % Site 1 | % Max Isoprenaline | Competition with Cimaterol (Dip) | n | Log EC150 | Log EC250 | % Site 1 | % Max Isoprenaline | n |
β1-WT | −9.28 ± 0.17 | −7.36 ± 0.21 | 42.3 ± 7.2 | 53.0 ± 2.9 | Yes | 6 | −9.10 ± 0.04 | −5.93 ± 0.18 | 57.1 ± 3.3 | 30.0 ± 2.0 | 8 |
β1-V189T | −9.37 ± 0.12 | −7.16 ± 0.06 | 45.1 ± 2.7 | 48.4 ± 4.6 | Yes | 6 | −8.87 ± 0.05 | −5.78 ± 0.14 | 67.1 ± 3.3 | 22.3 ± 2.9 | 5 |
β1-L195Q | −9.02 ± 0.09 | | | 37.4 ± 1.5 | Slight | 3 | −9.14 ± 0.08 | | | 27.9 ± 1.6 | 3 |
β1-W199Y | −9.28 ± 0.11 | | | 41.0 ± 3.2 | Slight | 4 | −9.02 ± 0.21 | −6.49 ± 0.18 | 71.7 ± 1.4 | 32.4 ± 3.0 | 4 |
β1-W199D | −9.80 ± 0.06 | | | 49.9 ± 1.0 | No | 6 | −8.96 ± 0.23 | | | 28.9 ± 1.8 | 4 |
β1-L195Q-W199Y | −9.62 ± 0.05 | | | 39.9 ± 3.7 | No | 4 | −9.33 ± 0.08 | | | 26.2 ± 3.0 | 4 |
β1-V189T-L195Q-W199Y | −9.52 ± 0.05 | | | 35.3 ± 6.3 | No | 3 | −9.11 ± 0.03 | | | 21.8 ± 1.4 | 4 |
β1-TM4 | −9.54 ± 0.06 | | | 30.9 ± 1.8 | No | 4 | −9.25 ± 0.08 | | | 23.0 ± 3.1 | 3 |
β2-WT | −9.81 ± 0.15 | | | 11.2 ± 1.6 | No | 4 | −9.58 ± 0.06 | | | 11.6 ± 0.4 | 4 |